A new advance has been made in the allergy world. Once cast aside as a simple irritation of the body to external stimuli, the attention to allergies and creating allergy therapy has — in the past –taken a back seat to other serious maladies. However, as physicians and scientists alike begin to understand allergies as a systematic, immunological health issue, therapies have risen to the occasion, the most recent — the advent of therapy droplets. Clinically known as sublingual immunotherapy, these droplets have replaced shots as the most effective way to inoculate patients and build tolerance. Inoculation was a technology championed in the 19th century, and some in the medical field feel it is a retrograde technology compared to what can be offered today. Shots are painful and in today's scientific and technological climate seem retrograde compared to what medicine could be offering in new therapy.
The medicine is similar to that of a shot in that the allergy is attacked by inserting that very allergy in the patient through under-the-tongue doses to build the patient's tolerance to that specific irritant. Instead of going to the doctor's office every week for shots, the sublingual therapy can be taken at home, given to children by their parents, after a short consultation and training with their physician. According to Johns Hopkins Medical, sublingual immunotherapy is incredibly safe and has been endorsed by the World Health Organization (WHO) as a "viable alternative to injection." There are no life-threatening side effects to the new therapy, but new users should be cautious of reactions similar to those observed with injections such as irritation at the dose sight, inflammation, etc.
Unfortunately, this therapy is not FDA approved. However, for products engineered to alleviate allergies, visit Allergy Be Gone on the web. Founded by Allen Barsano, who suffers from allergies himself, Allergy Be Gone has smart and safe products to protect you from external irritants inside and outside your home.
